Fig. 1
From: Response to pembrolizumab in a heavily treated patient with metastatic ovarian carcinosarcoma
Objective partial response in the left external iliac lymph nodes. (Left) Before treatment with pembrolizumab. (Right) After four cycles of pembrolizumab